Advertisement

Ads Placeholder
Loading...

Elan Corporation

6099.TJPX
Healthcare
Medical - Care Facilities
¥738.00
¥3.00(0.41%)
Japanese Market opens in 38h 20m

Elan Corporation Fundamental Analysis

Elan Corporation (6099.T) shows moderate financial fundamentals with a PE ratio of 16.12, profit margin of 4.99%, and ROE of 20.80%. The company generates $55.5B in annual revenue with strong year-over-year growth of 14.70%.

Key Strengths

ROE20.80%
Cash Position15.34%
Current Ratio1.69

Areas of Concern

Operating Margin7.71%
We analyze 6099.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 66.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
66.3/100

We analyze 6099.T's fundamental strength across five key dimensions:

Efficiency Score

Excellent

6099.T demonstrates superior asset utilization.

ROA > 10%
10.55%

Valuation Score

Excellent

6099.T trades at attractive valuation levels.

PE < 25
16.12
PEG Ratio < 2
1.84

Growth Score

Moderate

6099.T shows steady but slowing expansion.

Revenue Growth > 5%
14.70%
EPS Growth > 10%
-6.53%

Financial Health Score

Excellent

6099.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
1.69

Profitability Score

Weak

6099.T struggles to sustain strong margins.

ROE > 15%
20.80%
Net Margin ≥ 15%
4.99%
Positive Free Cash Flow
No

Key Financial Metrics

Is 6099.T Expensive or Cheap?

P/E Ratio

6099.T trades at 16.12 times earnings. This indicates a fair valuation.

16.12

PEG Ratio

When adjusting for growth, 6099.T's PEG of 1.84 indicates fair valuation.

1.84

Price to Book

The market values Elan Corporation at 3.09 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.09

EV/EBITDA

Enterprise value stands at 8.97 times EBITDA. This is generally considered low.

8.97

How Well Does 6099.T Make Money?

Net Profit Margin

For every $100 in sales, Elan Corporation keeps $4.99 as profit after all expenses.

4.99%

Operating Margin

Core operations generate 7.71 in profit for every $100 in revenue, before interest and taxes.

7.71%

ROE

Management delivers $20.80 in profit for every $100 of shareholder equity.

20.80%

ROA

Elan Corporation generates $10.55 in profit for every $100 in assets, demonstrating efficient asset deployment.

10.55%

Following the Money - Real Cash Generation

Operating Cash Flow

Elan Corporation generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Elan Corporation generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

6099.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

16.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.84

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.09

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.81

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.69

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.21

vs 25 benchmark

ROA

Return on assets percentage

0.11

vs 25 benchmark

ROCE

Return on capital employed

0.28

vs 25 benchmark

How 6099.T Stacks Against Its Sector Peers

Metric6099.T ValueSector AveragePerformance
P/E Ratio16.1228.45 Better (Cheaper)
ROE20.80%763.00% Weak
Net Margin4.99%-45265.00% (disorted) Weak
Debt/Equity0.050.34 Strong (Low Leverage)
Current Ratio1.692795.60 Neutral
ROA10.55%-16588.00% (disorted) Strong

6099.T outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Elan Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

121.30%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

138.48%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

478.83%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ